T1	location 74 83	Stockholm
T2	intervention 0 27	Hormone replacement therapy
T3	intervention-participants 659 662	188
T5	control-participants 677 680	190
T6	outcome 1025 1049	new breast cancer events
T7	iv-bin-abs 1051 1053	60
T8	cv-bin-abs 1078 1080	48
T11	outcome 1186 1202	local recurrence
T12	iv-bin-abs 1179 1181	11
T13	outcome 1210 1228	distant metastases
T14	iv-bin-abs 1207 1209	12
T15	cv-bin-abs 1236 1238	15
T16	cv-bin-abs 1243 1245	12
T17	outcome 1278 1307	contra-lateral breast cancers
T18	iv-bin-abs 1275 1277	14
T19	cv-bin-abs 1329 1333	four
T4	outcome 1409 1446	mortality or new primary malignancies
T9	outcome 1463 1483	number of new events
T10	outcome 1576 1586	recurrence
T20	outcome 1757 1766	mortality
T21	control 667 673	no HRT
